# Pentixapharm Announces Progress of Pivotal Phase 3 PANDA Study; Will Host Third Quarter Webcast on November 12, 2026

- Source: PR Newswire M&A
- Published: 2026-11-04T07:21:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/pentixapharm-announces-progress-of-pivotal-phase-3-panda-study-will-host-third-quarter-webcast-on-november-12-2026-302928975.html
- Canonical: https://groundlevelnews.com/story/pentixapharm-announces-progress-of-pivotal-phase-3-panda-study-will-ho-a87e24/

No FDA comments on the study protocol submitted in August 2026, including the primary endpoints and the planned number of approximately 325 patients; central U.S. ethics committee has approved the protocol and consent documents First patient enrollment continues to be expected in the...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._